Investor

Amgen's VC arm

Last cheque observed Jan 2021. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series B

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque2119days00hrs00min00sec
Median round$105MRounds led0 of 1
Pitch Amgen's VC arm

Amgen's VC arm highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2021

    1 round

  2. Jan
    Senti BiosciencesSeries B · US · Firms' own news pages$105MWith 8 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies Amgen's VC arm put money into.

Quick answers about Amgen's VC arm

What does Amgen's VC arm invest in?

Amgen's VC arm invests most often at Series B (100% of the rounds on record).

How active is Amgen's VC arm?

1 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2021.

What has Amgen's VC arm invested in recently?

Its most recent investments on record: Senti Biosciences (Series B, Jan 2021).

How big are Amgen's VC arm's cheques?

The median round it joins is $105M.

Is Amgen's VC arm investing now?

No investments in the last 12 months; the latest was in Jan 2021.

What kind of investor is Amgen's VC arm?

Amgen's VC arm is a growth equity firm.

Where does this information on Amgen's VC arm come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it